Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-04 · accession 0001209191-22-017066 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-08 | 2022-03-04+ | TEVA | Weiss Amir | CAO | M - OptEx | — | +5,967 | 24.6K | +32% | — |
| D | 2022-03-08 | 2022-03-04 | TEVA | Weiss Amir | CAO | A - Grant | $0.00 | +42.7K | 42.7K | New | $0 |
| DM | 2022-03-08 | 2022-03-04+ | TEVA | Weiss Amir | CAO | M - OptEx | $0.00 | -5,967 | 10.7K | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-03-04 | M | A | 2,403 | — | 20,994.41 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 2 | Common | Ordinary Shares | 2022-03-05 | M | A | 3,564 | — | 24,558.41 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 3 | Derivative | Restricted Share Units | 2022-03-04 | A | A | 42,707 | $0.00 | 42,707 | D | — · — to — | 42,707 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F4) Restricted share units were granted on March 4, 2022, with 10,676 vesting on each of March 4, 2023, March 4, 2024 and March 4, 2025 and 10,679 vesting on March 4, 2026. |
| 4 | Derivative | Restricted Share Units | 2022-03-04 | M | D | 2,403 | $0.00 | 2,406 | D | — · — to — | 2,403 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F3) Restricted share units were granted on March 4, 2019, with 2,403 having vested on March 4, 2022 and 2,406 vesting on March 4, 2023. |
| 5 | Derivative | Restricted Share Units | 2022-03-05 | M | D | 3,564 | $0.00 | 10,694 | D | — · — to — | 3,564 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F5) Restricted share units were granted on March 5, 2021, with 3,564 having vested on March 5, 2022, 3,564 vesting on each of March 5, 2023 and March 5, 2024 and 3,566 vesting on March 5, 2025. |